Larvol Delta - New-Data-Presented-at-American-Thoracic-Society-Meeting-Reinforces-the-Potential-of-an-Oral-Drug-Combination-Therapy-for-the-Treatment-of-Obstructive-Sleep-Apnea

reboxetine\oxybutynin (AD128) - Apnimed

https://www.businesswire.com/news/home/20210517005740/en/New-Data-Presented-at-American-Thoracic-Society-Meeting-Reinforces-the-Potential-of-an-Oral-Drug-Combination-Therapy-for-the-Treatment-of-Obstructive-Sleep-Apnea

May 17, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next